Acurx Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.2M | $3.9M | $3.7M |
| FY2025 | $2.4M | $7.7M | $7.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.2M | $3.9M | $3.7M |
| FY2025 | $2.4M | $7.7M | $7.6M |